Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transder...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Emre, Murat, Bernabei, Roberto, Blesa, Rafael, Bullock, Roger, Cunha, Luis, Daniëls, Hugo, Dziadulewicz, Edward, Förstl, Hans, Frölich, Lutz, Gabryelewicz, Tomasz, Levin, Oleg, Lindesay, James, Martínez‐Lage, Pablo, Monsch, Andreas, Tsolaki, Magda, Van Laar, Teus
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2010
Matèries:
Alzheimer's Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493902/
https://ncbi.nlm.nih.gov/pubmed/20370805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00141.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars